Climate change has become a common challenge faced by all mankind. Under the “Dual Carbon” goal of China’s carbon peak and carbon neutralization, the attention of all sectors of society to environmental, social and corporate governance (ESG) has been increasing day by day, and ESG management has become a stepping stone to achieve the sustainable development goals.
With the development goal of “carrying out the concept of environmental protection, achieving the value of social responsibility, being committed to becoming a leading sustainable pharmaceutical enterprise in China”, China Medical System Holdings Limited (“CMS” or the “Group”) has attached great importance to ESG management over the years, and adhered to compliance management, quality control of product and service, employee development and care, and green supply chain management, actively contributing to the ecological environment protection and the development of community and the pharmaceutical industry.
In the past year, CMS’s ESG-related performance was recognized by organizations at home and abroad: MSCI-ESG rating was upgraded to “AA”, reaching the global leading level; winning the “Best ESG” in all Small & Mid cap companies in Healthcare and Pharmaceuticals sector by Institutional Investor, an international authoritative financial magazine; ranking seventh on the “CSR Ranking of Pharmaceutical Enterprises in 2020” by Southern Weekly.
CMS ESG Stakeholder Survey
We sincerely invite you to participate in the Group’s ESG Stakeholder Survey in 2021 so as to understand the views and expectations of stakeholders on ESG management, reasonably optimize the Group’s ESG management strategy, further improve the corporate governance, and timely respond to the demands of stakeholders.
Please click the link below to participate in the survey:
This survey is anonymous. It will take approximately 5 minutes.
Please fill out the questionnaire by November 18th, 2021
Thank you for your participation. We will listen to your voice attentively.